
Despite Potential Dangers, FDA Advisors Advise Against the First-Ever RSV Vaccination from Pfizer
Despite safety concerns raised after two trial participants experienced a rare neurological disease, the Food and Drug Administration’s independent advisors on Tuesday (February 28, 2023)…